AIG
LFCR icon

American International Group’s Lifecore Biomedical LFCR Stock Holding History

American International Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,645
Closed -$47.7K – 3128
2023
Q1 		$47.7K Buy
12,645
+252
+2% +$1.41K ﹤0.01% 2729
2022
Q4 		$80.3K Sell
12,393
-45
-0.4% -$371 ﹤0.01% 2600
2022
Q3 		$111K Buy
12,438
+175
+1% +$1.78K ﹤0.01% 2494
2022
Q2 		$122K Sell
12,263
-720
-6% -$7.13K ﹤0.01% 2470
2022
Q1 		$150K Sell
12,983
-916
-7% -$10.2K ﹤0.01% 2414
2021
Q4 		$154K Sell
13,899
-415
-3% -$4.03K ﹤0.01% 2514
2021
Q3 		$132K Sell
14,314
-340
-2% -$3.7K ﹤0.01% 2663
2021
Q2 		$165 Sell
14,654
-451
-3% -$5.2K ﹤0.01% 2628
2021
Q1 		$160 Buy
15,105
+40
+0.3% +$450 ﹤0.01% 2484
2020
Q4 		$163 Sell
15,065
-432
-3% -$4.46K ﹤0.01% 2383
2020
Q3 		$151K Sell
15,497
-353
-2% -$3.36K ﹤0.01% 2299
2020
Q2 		$126K Buy
15,850
+519
+3% +$5.36K ﹤0.01% 2373
2020
Q1 		$133K Sell
15,331
-886
-5% -$9.22K ﹤0.01% 2144
2019
Q4 		$183K Buy
16,217
+783
+5% +$8.33K ﹤0.01% 2280
2019
Q3 		$168K Sell
15,434
-108
-0.7% -$1.18K ﹤0.01% 2289
2019
Q2 		$146K Sell
15,542
-46
-0.3% -$464 ﹤0.01% 2438
2019
Q1 		$191K Sell
15,588
-2,261
-13% -$27.6K ﹤0.01% 2232
2018
Q4 		$211K Sell
17,849
-137
-0.8% -$1.88K ﹤0.01% 2159
2018
Q3 		$259K Buy
17,986
+325
+2% +$4.49K ﹤0.01% 2273
2018
Q2 		$263K Buy
17,661
+484
+3% +$6.73K ﹤0.01% 2211
2018
Q1 		$224K Sell
17,177
-924
-5% -$12.1K ﹤0.01% 2188
2017
Q4 		$228K Buy
18,101
+86
+0.5% +$1.09K ﹤0.01% 2245
2017
Q3 		$233K Buy
18,015
+1,347
+8% +$17.8K ﹤0.01% 2209
2017
Q2 		$248K Buy
16,668
+182
+1% +$2.53K ﹤0.01% 2150
2017
Q1 		$198K Buy
16,486
+1,102
+7% +$14K ﹤0.01% 2187
2016
Q4 		$212K Sell
15,384
-40
-0.3% -$554 ﹤0.01% 2137
2016
Q3 		$207K Buy
15,424
+23
+0.1% +$279 ﹤0.01% 2146
2016
Q2 		$166K Sell
15,401
-380
-2% -$4.19K ﹤0.01% 2264
2016
Q1 		$166K Sell
15,781
-1,080
-6% -$11.9K ﹤0.01% 2942
2015
Q4 		$200K Sell
16,861
-28
-0.2% -$344 ﹤0.01% 2840
2015
Q3 		$197K Buy
16,889
+18
+0.1% +$238 ﹤0.01% 2852
2015
Q2 		$243K Sell
16,871
-392
-2% -$5.66K ﹤0.01% 2836
2015
Q1 		$241K Hold
17,263
– – ﹤0.01% 2789
2014
Q4 		$238K Sell
17,263
-241
-1% -$3.11K ﹤0.01% 2795
2014
Q3 		$214K Sell
17,504
-4,014
-19% -$50.1K ﹤0.01% 2899
2014
Q2 		$269K Sell
21,518
-113
-0.5% -$1.33K ﹤0.01% 2721
2014
Q1 		$241K Sell
21,631
-1,877
-8% -$20.6K ﹤0.01% 2673
2013
Q4 		$285K Sell
23,508
-673
-3% -$8.04K ﹤0.01% 2463
2013
Q3 		$295K Buy
24,181
+1,585
+7% +$22.1K ﹤0.01% 2373
2013
Q2 		$298K Buy
+22,596
New +$312K ﹤0.01% 2237

Other funds holding LFCR

GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

American International Group's LFCR Position: Q2 2023 in Review

American International Group sold out of Lifecore Biomedical (LFCR) in Q2 2023, closing a stake of 12,645 shares — an estimated $47.7K sold.

American International Group first reported a position in LFCR in Q2 2013 and held it in 40 quarters. The position peaked at $298K in Q2 2013. 75 funds tracked by Wall St. Rank hold LFCR as of Q2 2023.

  • American International Group reported no remaining Lifecore Biomedical position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 12,645 Lifecore Biomedical shares in Q2 2023, an estimated $47.7K.
  • American International Group first reported a position in Lifecore Biomedical in Q2 2013 and held it in 40 quarters.
  • American International Group's Lifecore Biomedical position peaked at $298K in Q2 2013.
  • 75 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.